Patient acceptability was assessed with the Performance Domain score from the PASAPQ. The score is a mean of 7 items on a scale from 0 (very dissatisfied) to 100 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

Patient acceptability was assessed with the Performance Domain score from the PASAPQ. The score is a mean of 7 items on a scale from 0 (very dissatisfied) to 100 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

Patient acceptability was assessed with the Performance Domain score from the PASAPQ. The score is a mean of 7 items on a scale from 0 (very dissatisfied) to 100 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

Patient acceptability was assessed with the Performance Domain score from the PASAPQ. The score is a mean of 7 items on a scale from 0 (very dissatisfied) to 100 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

Patient acceptability was assessed with the Performance Domain score from the PASAPQ. The score is a mean of 7 items on a scale from 0 (very dissatisfied) to 100 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

Patient satisfaction was assessed by asking: "Overall, how satisfied are you with your inhaler?". Responses were made on a scale from 1 (very dissatisfied) to 7 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

Patient satisfaction was assessed by asking: "Overall, how satisfied are you with your inhaler?". Responses were made on a scale from 1 (very dissatisfied) to 7 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

Patient satisfaction was assessed by asking: "Overall, how satisfied are you with your inhaler?". Responses were made on a scale from 1 (very dissatisfied) to 7 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

Patient satisfaction was assessed by asking: "Overall, how satisfied are you with your inhaler?". Responses were made on a scale from 1 (very dissatisfied) to 7 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

Patient satisfaction was assessed by asking: "Overall, how satisfied are you with your inhaler?". Responses were made on a scale from 1 (very dissatisfied) to 7 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

Patient satisfaction was assessed by asking: "Overall, how satisfied are you with your inhaler?". Responses were made on a scale from 1 (very dissatisfied) to 7 (very satisfied).

Treated Set is defined as all patients who were randomized and received study drug

CCQ symptom domain score assessed patient feelings or limitations due to their COPD on a scale from 0 (not limited) to 6 (totally limited).

Treated Set is defined as all patients who were randomized and received study drug

CCQ symptom domain score assessed patient feelings or limitations due to their COPD on a scale from 0 (not limited) to 6 (totally limited).

Treated Set is defined as all patients who were randomized and received study drug

CCQ symptom domain score assessed patient feelings or limitations due to their COPD on a scale from 0 (not limited) to 6 (totally limited).

Treated Set is defined as all patients who were randomized and received study drug

CCQ symptom domain score assessed patient feelings or limitations due to their COPD on a scale from 0 (not limited) to 6 (totally limited).

Treated Set is defined as all patients who were randomized and received study drug

CCQ symptom domain score assessed patient feelings or limitations due to their COPD on a scale from 0 (not limited) to 6 (totally limited).

Treated Set is defined as all patients who were randomized and received study drug

CCQ symptom domain score assessed patient feelings or limitations due to their COPD on a scale from 0 (not limited) to 6 (totally limited).

Treated Set is defined as all patients who were randomized and received study drug

Physicians evaluated the patient's overall clinical condition on a scale ranging from "poor" (score 1 or 2) to "excellent" (score 7 or 8).

Treated Set is defined as all patients who were randomized and received study drug

Physicians evaluated the patient's overall clinical condition on a scale ranging from "poor" (score 1 or 2) to "excellent" (score 7 or 8).

Treated Set is defined as all patients who were randomized and received study drug

Physicians evaluated the patient's overall clinical condition on a scale ranging from "poor" (score 1 or 2) to "excellent" (score 7 or 8).

Treated Set is defined as all patients who were randomized and received study drug

Physicians evaluated the patient's overall clinical condition on a scale ranging from "poor" (score 1 or 2) to "excellent" (score 7 or 8).

Treated Set is defined as all patients who were randomized and received study drug

Physicians evaluated the patient's overall clinical condition on a scale ranging from "poor" (score 1 or 2) to "excellent" (score 7 or 8).

Treated Set is defined as all patients who were randomized and received study drug

Physicians evaluated the patient's overall clinical condition on a scale ranging from "poor" (score 1 or 2) to "excellent" (score 7 or 8).

Treated Set is defined as all patients who were randomized and received study drug

Change from test-day baseline in Forced Expiratory Volume in 1 second (FEV1) at 1 hour post dose on test day 1.

Treated Set is defined as all patients who were randomized and received study drug

Change from test-day baseline in Forced Expiratory Volume in 1 second (FEV1) at 1 hour post dose at Week 12

Treated Set is defined as all patients who were randomized and received study drug

Change from test-day baseline in Forced Expiratory Volume in 1 second (FEV1) at 1 hour post dose at Week 24

Treated Set is defined as all patients who were randomized and received study drug

Change from test-day baseline in Forced Expiratory Volume in 1 second (FEV1) at 1 hour post dose at Week 48

Treated Set is defined as all patients who were randomized and received study drug

Change from test-day baseline in Forced Vital Capacity (FVC) at 1 hour post dose on test day 1.

Treated Set is defined as all patients who were randomized and received study drug

Change from test-day baseline in Forced Vital Capacity (FVC) at 1 hour post dose at Week 12

Treated Set is defined as all patients who were randomized and received study drug

Change from test-day baseline in Forced Vital Capacity (FVC) at 1 hour post dose at Week 24

Treated Set is defined as all patients who were randomized and received study drug

Change from test-day baseline in Forced Vital Capacity (FVC) at 1 hour post dose at Week 48

Treated Set is defined as all patients who were randomized and received study drug

Mean number of puffs of daily rescue medication use (albuterol use per 24 hour period) in two weeks prior to week 0

Treated Set is defined as all patients who were randomized and received study drug

Mean number of puffs of daily rescue medication use (albuterol use per 24 hour period) in two weeks prior to week 3

Treated Set is defined as all patients who were randomized and received study drug

Mean number of puffs of daily rescue medication use (albuterol use per 24 hour period) in two weeks prior to week 12

Treated Set is defined as all patients who were randomized and received study drug

Mean number of puffs of daily rescue medication use (albuterol use per 24 hour period) in two weeks prior to week 24

Treated Set is defined as all patients who were randomized and received study drug

Mean number of puffs of daily rescue medication use (albuterol use per 24 hour period) in two weeks prior to week 36

Treated Set is defined as all patients who were randomized and received study drug

Mean number of puffs of daily rescue medication use (albuterol use per 24 hour period) in two weeks prior to week 48

Treated Set is defined as all patients who were randomized and received study drug

Treated Set is defined as all patients who were randomized and received study drug

Treated Set is defined as all patients who were randomized and received study drug